For Immediate Release
Contact: Lisa Finger, 919-933-2021, lfinger@biosignia.com


BioSignia appoints Dr. T. Colin Campbell to Board of Directors

October 7, 2011 -- BioSignia today announced the appointment of company founder, Dr. T. Colin Campbell to BioSignia’s Board of Directors. Hailed by the scientific community, Dr. Campbell’s groundbreaking work demonstrated that understanding the long-term impact of lifestyle choices is central to preventing chronic disease. Motivated by his father's life's work, Nelson Campbell joined with his father to lead the founding of BioSignia in 1996. Their early objective was to create a statistical model that assessed the future onset of chronic illness based on a unique individual’s characteristics.

For more than forty years, Dr. T. Colin Campbell has been at the forefront of nutrition research. His legacy, the China Project, is the most comprehensive study of health and nutrition ever conducted. Dr. Campbell is the Jacob Gould Schurman Professor Emeritus of Nutritional Biochemistry at Cornell University. He has more than seventy grant-years of peer-reviewed research funding and authored more than 300 research papers and coauthor of the bestselling the book, The China Study: Startling Implications for Diet, Weight Loss and Long-term Health.

BioSignia, Inc. • 401 Harrison Oaks Blvd., Suite 120 • Cary, NC 27513 • (919) 933-2021 • (888) 324-6627